Zambon S.P.A.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
4
Ending by 2030
Sep 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 25, 2027The maintenance fee for Safinamide for treating myotonia (US 11,707,441) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
- 1 fee due Mar 22, 2027The maintenance fee for Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions obtained from the same and process for their preparation (US 9,138,407) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.
- 1 fee due Apr 22, 2027The maintenance fee for Pharmaceutical composition containing budesonide and formoterol (US 10,449,147) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
- 1 fee due Jun 30, 2027The maintenance fee for Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation (US 10,517,828) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Aug 2, 2027The maintenance fee for Multipurpose gel for vaginal dryness with direct and delayed effect (US 9,248,151) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.
- 2 fees due Sep 5 to 10, 2027 · next Sep 5
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,252,334 | Dry powder pharmaceutical compositions comprising surfactants, hydrophobic active principles, and water-soluble excipients, process of preparing, and stable aqueous suspensions thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,287,846 | Cosmetic or dermatological preparations comprising N-acetylcysteine In force · From the USPTO record | In force | From the USPTO record | |
| US 9,138,407 | Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions obtained from the same and process for their preparation In force · From the USPTO record | In force | From the USPTO record | |
| US 8,522,774 | Aerosol apparatus, in particular for children In force · From the USPTO record | In force | From the USPTO record | |
| US 9,248,151 | Multipurpose gel for vaginal dryness with direct and delayed effect In force · From the USPTO record | In force | From the USPTO record | |
| US 10,226,421 | A Pharmaceutical Composition Containing Budesonide and Formoterol In force · Medium confidence | In force | Medium confidence | |
| US 10,583,082 | Composition comprising at least two dry powders obtained by spray drying to increase the stability of the formulation In force · From the USPTO record | In force | From the USPTO record | |
| US 9,808,427 | Swallowable N-acetylcysteine tablets In force · From the USPTO record | In force | From the USPTO record | |
| US 10,449,147 | Pharmaceutical composition containing budesonide and formoterol In force · From the USPTO record | In force | From the USPTO record | |
| US 10,517,828 | Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 17: 33 lapsed for an unpaid fee · 170 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
6 pending · 1 abandoned · 15 no status recorded